Baxter International Inc. (NYSE: BAX) will acquire Gambro AB, a Swedish medical product-design company for about $4 billion.

Gambro designs and manufactures medical technology products, such as dialysis products and therapies for patients with acute or chronic kidney disease. The company has annual sales of about $1.6 billion.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.